(Q46987995)

27 December 2017

title

Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome (English)

1 reference

27 December 2017

1 reference

ventricular fibrillation

1 reference

Atilio Abud

1

1 reference

27 December 2017

Daniel Bagattin

series ordinal

2

1 reference

27 December 2017

Raul Goyeneche

series ordinal

3

1 reference

27 December 2017

Carlos Becker

series ordinal

4

1 reference

27 December 2017

publication date

1 February 2006

1 reference

27 December 2017

Journal of Cardiovascular Electrophysiology

published in

1 reference

27 December 2017

volume

17

1 reference

27 December 2017

issue

2

1 reference

27 December 2017

page(s)

210-212

1 reference

27 December 2017

Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

The Brugada syndrome: clinical, electrophysiologic and genetic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

"Brugada" syndrome: clinical data and suggested pathophysiological mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Efficacy of quinidine in high-risk patients with Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Successful use of quinidine in treatment of electrical storm in Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Electrical storm in Brugada syndrome successfully treated using isoprenaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Effectiveness of sotalol treatment in symptomatic Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

A newly characterized SCN5A mutation underlying Brugada syndrome unmasked by hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

Electrocardiographic pattern of Brugada syndrome disclosed by a febrile illness: clinical and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2005.00290.X

10.1111/J.1540-8167.2005.00290.X

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017